טוען...
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma
BACKGROUND: Thalidomide maintenance therapy after stem cell transplantation resulted in increased progression-free survival and overall survival in a few trials, but its role in non-transplant eligible patients with multiple myeloma remains unclear. This study assessed the impact of thalidomide-inte...
שמור ב:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ferrata Storti Foundation
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2930957/ https://ncbi.nlm.nih.gov/pubmed/20418244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.020586 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|